Thermo Fisher's $12.5B deal for Qiagen falls through, as COVID-19 test demand lights new path forward | Fierce Biotech
Thermo Fisher Expands Diagnostics Capabilities with $11.5 Billion Takeover of Qiagen | BioSpace
Top Tier Firms Advise on Thermo Fisher's $11.5 Billion Acquisition of Qiagen | Law.com International
Qiagen falls after report not in talks with any suitors (NYSE:QGEN) | Seeking Alpha
Thermo Fisher to buy diagnostics group Qiagen in $11.5bn deal | Financial Times
Thermo Fisher buys Qiagen after all | Evaluate
QIAGEN on Twitter: "QIAGEN shareholders approve all agenda items related to acquisition by Thermo Fisher Scientific at Annual General Meeting. Full press release: https://t.co/R4wKLVyIrW https://t.co/Q4Dd8GpQFy" / Twitter
Thermo Fisher Scientific to Acquire QIAGEN N.V.
Qiagen Shares Jump as Thermo Fisher Is Said to Weigh Acquisition - Bloomberg
BREAKING: Thermo Fisher drops bid for Qiagen - Drug Delivery Business
Thermo Fisher to Expand Coronavirus, Infectious Disease Dx with Planned $11.5B QIAGEN Acquisition
Thermo Fisher nixes $12.7B Qiagen acquisition - Washington Business Journal
Qiagen chairman quits after Thermo Fisher's takeover bid fails | Reuters.com
Thermo Fisher Is Buying Qiagen for $11.5 Billion. It's a 'Home Run' Deal. | Barron's
Why did the Thermo Fisher-Qiagen deal fall apart?
Thermo Fisher looks to buy fellow diagnostics maker Qiagen: Bloomberg | Fierce Biotech
Thermo Fisher Scientific to Acquire QIAGEN N.V. · BioBuzz
How COVID-19 Testing Demand Threw off Thermo Fisher's Acquisition of Qiagen
Thermo Fisher Increases Its Buyout Price for Qiagen, but Investors Ask for More | The Motley Fool
Thermo Fisher's €10.7bn takeover of Qiagen collapses after investor revolt | Financial Times
Qiagen Jumps on Report Thermo Fisher Is Considering a Bid - TheStreet
Thermo Fisher, QIAGEN Part Ways as COVID-19 Fuels Collapse of $12.5B Deal
Thermo Fisher's €10.7bn takeover of Qiagen collapses after investor revolt | Financial Times
Thermo Fisher increases takeover price for Qiagen by $1bn
How COVID-19 Testing Demand Threw off Thermo Fisher's Acquisition of Qiagen
